Shanghai-based biotech drug company ZAI Lab has received US$30 million Series A financing led by Qiming Venture Partners, according to ZAI Lab’s official announcement. KPCB, Sequoia Capital and TF Capital also participate in this round of financing. The funding will be used to support ZAI Lab’s clinical development programs, as well as the company’s licensing […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.